Christine Phillips, PhD
Director, North American Regulatory Affairs: Covid 19 Monoclonal Antibodies @ Eli Lilly and Company
About Christine Phillips, PhD
Christine Phillips, PhD, serves as the Director of North American Regulatory Affairs for COVID-19 Monoclonal Antibodies at Eli Lilly and Company. With extensive experience in regulatory affairs across various therapeutic areas, she has played a key role in securing emergency use authorization for critical treatments during the pandemic.